CymaBay Therapeutics Inc. (CBAY)
NASDAQ: CBAY
· Real-Time Price · USD
32.48
0.01 (0.03%)
At close: Mar 21, 2024, 9:00 PM
CymaBay Therapeutics Revenue
CymaBay Therapeutics reported an annual revenue of $31.07M, reflecting a 0% growth. For the quarter ending December 31, 2023, CymaBay Therapeutics generated $57K in revenue.
Revenue (ttm)
31.07M
Revenue Growth
n/a
Price / Sales Ratio
80.73
Revenue / Employee
307.65K
Employees
101
Market Cap
3.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 31.07M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | -100.00% |
| Dec 31, 2017 | 10M | +Infinity% |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | -100.00% |
| Dec 31, 2012 | 3.05M | n/a |